BACKGROUND: Few studies have examined timeliness of diagnostic evaluation of abnormal cancer screening tests in community health centers. METHODS: Using medical record review, timeliness of diagnosis was assessed among 317 people having either breast or colorectal-related abnormalities. RESULTS: For 241 subjects (76.0%) who reached clinical resolution, the median time to diagnostic resolution was 37 days. People with breast abnormalities had more than twice the odds (adjusted odds ratio: 2.84) of reaching diagnostic resolution within 180 days compared with patients with colorectal abnormalities. We found, however, no evidence of disparate outcomes according to patient race/ethnicity, insurance status, or spoken language. CONCLUSIONS: Diagnostic evaluations are often either not completed or are delayed after a cancer-related abnormality is discovered. Further research is needed to understand the patient, provider, and health care system factors that contribute to these delays. There was no evidence of cancer disparities in the community health centers studied.
BACKGROUND: Few studies have examined timeliness of diagnostic evaluation of abnormal cancer screening tests in community health centers. METHODS: Using medical record review, timeliness of diagnosis was assessed among 317 people having either breast or colorectal-related abnormalities. RESULTS: For 241 subjects (76.0%) who reached clinical resolution, the median time to diagnostic resolution was 37 days. People with breast abnormalities had more than twice the odds (adjusted odds ratio: 2.84) of reaching diagnostic resolution within 180 days compared with patients with colorectal abnormalities. We found, however, no evidence of disparate outcomes according to patient race/ethnicity, insurance status, or spoken language. CONCLUSIONS: Diagnostic evaluations are often either not completed or are delayed after a cancer-related abnormality is discovered. Further research is needed to understand the patient, provider, and health care system factors that contribute to these delays. There was no evidence of cancer disparities in the community health centers studied.
Authors: Kristen J Wells; Cathy D Meade; Ercilia Calcano; Ji-Hyun Lee; Desiree Rivers; Richard G Roetzheim Journal: J Cancer Educ Date: 2011-12 Impact factor: 2.037
Authors: Rose C Maly; Barbara Leake; Cynthia M Mojica; Yihang Liu; Allison L Diamant; Amardeep Thind Journal: J Womens Health (Larchmt) Date: 2011-04-12 Impact factor: 2.681
Authors: Stacey A Fedewa; Stephen B Edge; Andrew K Stewart; Michael T Halpern; Nicole M Marlow; Elizabeth M Ward Journal: J Health Care Poor Underserved Date: 2011-02
Authors: Lisa C Richardson; Janet Royalty; William Howe; William Helsel; William Kammerer; Vicki B Benard Journal: Am J Public Health Date: 2009-12-17 Impact factor: 9.308
Authors: Debra Wujcik; Yu Shyr; Ming Li; Margaret F Clayton; Lee Ellington; Usha Menon; Kathi Mooney Journal: Oncol Nurs Forum Date: 2009-11 Impact factor: 2.172
Authors: Swann A Adams; Emily R Smith; James Hardin; Irene Prabhu-Das; Jeanette Fulton; James R Hebert Journal: Cancer Date: 2009-12-15 Impact factor: 6.860